Clinical Trials in Chicago

Showing 20141-20160 of 20,493 trials

Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients

NCT00046371

The purpose of this study is to examine the immunological response rate to administration of the THERATOPE® vaccine in women with stable metastatic breast cancer who are being treated with aromatase inhibitors or Faslodex® and who do not require chemotherapy. Post-menopausal women on aromatase inhibitors or Faslodex® alone and pre-menopausal women on aromatase inhibitors plus luteinising hormone-releasing hormone (LH/RH)-agonist may be eligible to be enrolled. Patients must not have had radiotherapy or major surgery within four (4) weeks prior to entering the study. Information about the safety and tolerability of administration of the THERATOPE® vaccine will also be gathered during the course of the study.

Breast Neoplasms

Oncothyreon Canada Inc.Started Aug 2002

Berkeley, California, United States • San Francisco, California, United States • Santa Monica, California, United States +14 more locations

TERMINATEDPhase 32.2 miles

Treatment of Major Depressive Disorder With Psychotic Features.

NCT00174590

The purpose of this study is to determine the safety and efficacy of risperidone monotherapy in the treatment of psychotic depression. We hypothesize that risperidone is as equally as effective as haloperidol plus sertraline for depression with psychotic features

Major Depression With Psychotic Features

Rush University Medical Center30 participantsStarted Sep 2001

Chicago, Illinois, United States

Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients

Treatment of Major Depressive Disorder With Psychotic Features.

Find Trials by Condition in Chicago

Treatment of Depression With Quetiapine

To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids

Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma

XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema

Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder

Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder

PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease

Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active Rheumatoid Arthritis

A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder

A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma

Efficacy Study of EVT 201 in the Treatment of Elderly Patients With Daytime Sleepiness

Study of Rebamipide Eye Drops to Treat Dry Eye

Endoscopic Full-Thickness Plication for the Treatment of GERD: Long-Term Multicenter Results

Study of the NDO Endoscopic Plication System For the Treatment of Symptomatic Gastroesophageal Reflux Disease

Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™

Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects

Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis

A Study of CC-5013 in the Treatment of Complex Regional Pain Syndrome (CRPS)